$SVRA

$4.81▲ +0.6% YTD

3 SEC 13D/G filings tracked · Last updated Oct 21, 2026

Filing History

CP $4.81▲ +0.6%Oct 21, 2026 · ThinkSabio Blog

$SVRA Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis…

News

SVRA ▼ -1.8% - Savara Inc.

CP $4.84▲ -1.8%Oct 12, 2026 · ThinkSabio Blog

$SVRA Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pu…

SEC 13D/G

SVRA - Savara Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$5.41▼ -4.08%Aug 14, 2026 · ThinkSabio Blog

$SVRA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #SVRA Savara Inc. : $5.41 Sector: Healthcare | YTD: 🔽 -4.08% The…